Umberto Pacetti
About
In The Last Decade
Umberto Pacetti
10 papers receiving 320 citations
Peers
Comparison fields: 5 of 70
- Oncology 173
- Dermatology 56
- Surgery 56
- Molecular Biology 53
- Pulmonary and Respiratory Medicine 46
Countries citing papers authored by Umberto Pacetti
This map shows the geographic impact of Umberto Pacetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Umberto Pacetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Umberto Pacetti more than expected).
Fields of papers citing papers by Umberto Pacetti
This network shows the impact of papers produced by Umberto Pacetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Umberto Pacetti. The network helps show where Umberto Pacetti may publish in the future.
Co-authorship network of co-authors of Umberto Pacetti
This figure shows the co-authorship network connecting the top 25 collaborators of Umberto Pacetti. A scholar is included among the top collaborators of Umberto Pacetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Umberto Pacetti. Umberto Pacetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | Single-dose palonosetron and dose-reduced regimen of dexamethasone in preventing nausea and vomiting by anthracycline-including chemotherapy in patients with early breast cancer. | 1 |
| 3 | 3 | |
| 4 | Bisphosphonates and oral cavity avascular bone necrosis: a review of twelve cases. | 24 |
| 5 | Clinical experience with bevacizumab in colorectal cancer. | 12 |
| 6 | Epirubicin plus docetaxel in metastatic breast cancer: escalating dose does not improve efficacy. A phase II study. | 5 |
| 7 | 45 | |
| 8 | 238 | |
| 9 | 3 | |
| 10 | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.